tommyd Posted December 6, 2011 Share Posted December 6, 2011 Halpern crows about BOL-148 in an article by the Bloomberg news service. Already, LSD and psilocybin research by psychiatrist John Halpern at Harvard has led to a drug, dubbed BOL-148, being developed by Boston-based startup Entheogen Corp. The company is studying BOL-148, an LSD derivative, as a treatment for cluster headaches, sometimes called suicide headaches because theyÂ’re so painful that sufferers often kill themselves, said Halpern, EntheogenÂ’s co-founder. http://www.bloomberg.com/news/2011-12-06/-magic-mushrooms-return-to-psychology-labs-40-years-after-leary.html Quote Link to comment Share on other sites More sharing options...
Bejeeber Posted December 6, 2011 Share Posted December 6, 2011 Ooh good catch Tommy D, thanks. That article certainly is a good thing to have out there in the mainstream media IMO, and I see it also touches on the positive after effect a psychedelic mushroom experience can have on a person's outlook, as some of us have personally reported here. [smiley=thumbup.gif] Quote Link to comment Share on other sites More sharing options...
spiny Posted December 7, 2011 Share Posted December 7, 2011 I volunteer to help. After all, a med made EXPRESSLY for CH would be wonderful, wouldn't it? 8-) I bet it would beat the sometimes lousy seconds we get from the drug companies! > spiny Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.